Search Results

Showing of 1 until 12 from 16 result(s)

Search for: Jaime E. Hallak

Effect of two oral formulations of cannabidiol on responses to emotional stimuli in healthy human volunteers: pharmaceutical vehicle matters
José A. Crippa; Luiz C. Pereira Junior; Lívia C. Pereira; Patrícia M. Zimmermann; Liberato Brum Junior; Letícia M. Rechia; Isabella Dias; Jaime E. Hallak; Alline C. Campos; Francisco S. Guimarães; Regina H. Queiroz; Antonio W. Zuardi
Braz J Psychiatry. 2022;44(1):15-20 - ORIGINAL ARTICLE
Unveiling ayahuasca psychopharmacology: the accomplishments of Jordi Riba (1968-2020)
Rafael G. dos Santos; Draulio B. Araujo; Rafael F. Sanches; Jaime E. Hallak
Braz J Psychiatry. 2021;43(6):565-566 - EDITORIALS
Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study
Carolina de Meneses-Gaya; José A. Crippa; Jaime E. Hallak; André Q. Miguel; Ronaldo Laranjeira; Rodrigo A. Bressan; Antonio W. Zuardi; Acioly L. Lacerda
Braz J Psychiatry. 2021;43(5):467-476 - ORIGINAL ARTICLE
Increased body sway in phobic patients exposed to images of spiders
Ila M.P. Linares; Antonio E. Nardi; Francisco S. Guimarães; Katia C. Arrais; Marcos H. Chagas; Flavia L. Osório; Jaime E. Hallak; Antonio W. Zuardi; Norberto C. Coimbra; José A. Crippa
Braz J Psychiatry. 2021;43(5):477-483 - ORIGINAL ARTICLE
Nitrous oxide as an adjunctive therapy in major depressive disorder: a randomized controlled double-blind pilot trial
Mara C. Guimarães; Tiago M. Guimarães; Jaime E. Hallak; João Abrão; João P. Machado-de-Sousa
Braz J Psychiatry. 2021;43(5):484-493 - ORIGINAL ARTICLE
Risk assessment of ayahuasca use in a religious context: self-reported risk factors and adverse effects
Ícaro Durante; Rafael G. dos Santos; José C. Bouso; Jaime E. Hallak
Braz J Psychiatry. 2021;43(4):362-369 - ORIGINAL ARTICLE
Hallucinogens/psychedelics resurrected as new tools in psychiatric therapy
Rafael G. dos Santos; José C. Bouso; Jaime E. Hallak
Braz J Psychiatry. 2021;43(2):119-120 - EDITORIALS
Biological bases for a possible effect of cannabidiol in Parkinson's disease
Nilson C. Ferreira-Junior; Alline C. Campos; Francisco S. Guimarães; Elaine Del-Bel; Patrícia M. da R. Zimmermann; Liberato Brum Junior; Jaime E. Hallak; José A. Crippa; AntonioW. Zuardi
Braz J Psychiatry. 2020;42(2):218-224 - SPECIAL ARTICLE
Schizophrenia, the forgotten disorder: the scenario in Brazil
Gabriela Matos; Francisco B. Guarniero; Jaime E. Hallak; Rodrigo A. Bressan
Braz J Psychiatry. 2015;37(4):269-270 - EDITORIALS
Psychotic syndrome secondary to meningioma treated with a low dose of olanzapine
Joao P. Maia-de-Oliveira; Lizie E. Brasileiro; Carlos E. Correia; Joao P. Machado-de-Sousa; Jaime E. Hallak
Braz J Psychiatry. 2015;37(2):179-180 - LETTERS TO THE EDITORS
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
Flávia de L. Osório; Rafael F. Sanches; Ligia R. Macedo; Rafael G. dos Santos; Joao P. Maia-de-Oliveira; Lauro Wichert-Ana; Draulio B. de Araujo; Jordi Riba; José A. Crippa; Jaime E. Hallak
Braz J Psychiatry. 2015;37(1):13-20 - ORIGINAL ARTICLE
Structural and functional neuroimaging findings associated with the use of clozapine in schizophrenia: a systematic review
Giovana J. Garcia; Marcos H. Chagas; Carlos H. Silva; Joao P. Machado-de-Sousa; José A. Crippa; Jaime E. Hallak
Braz J Psychiatry. 2015;37(1):71-79 - REVIEW ARTICLES

© 2026 All rights reserved